Hepatology

Cover image for Vol. 60 Issue 3

Edited By: Michael H. Nathanson

Impact Factor: 11.19

ISI Journal Citation Reports © Ranking: 2013: 3/74 (Gastroenterology & Hepatology)

Online ISSN: 1527-3350

Associated Title(s): Clinical Liver Disease, Liver Transplantation

Access Chinese Articles now online


指导建议:

消化道内镜丙泊酚的非麻醉专科医师应用的指导建议
Nonanesthesiologist administration of propofol for GI endoscopy

病毒性肝炎:

聚乙二醇干扰素联合利巴韦林治疗对转氨酶正常的 法国慢性丙型肝炎患者发病率和死亡率的影响
Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France

初治基因1 型合并胰岛素抵抗的慢性丙型肝炎患者,在聚乙 二醇干扰素联合利巴韦林标准治疗的基础上加用 二甲双胍治疗的研究
Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

肝功能受损的慢性乙型肝炎患者在恩替卡韦治疗期间发生严重乳酸性酸中毒
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

血清乙型肝炎病毒表面抗原和乙型肝炎病毒e 抗原滴度:疾病阶段影响其与病毒载量和肝内乙型肝炎病毒标记物的相关性
Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

慢性乙肝病毒感染者乙肝表面抗原清除与肝癌发生风险的队列研究
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

恩替卡韦在伴有轻度丙氨酸氨基转移酶升高及肝脏病理组织损伤的慢性乙型肝炎患者中的疗效评估
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage

乙肝病毒抗体抗病毒新机制:抑制病毒颗粒从宿主细胞内释放
Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells

聚乙二醇干扰素λ1 单用或联合利巴韦林治疗1 型慢性丙型肝炎病毒感染者的1b 期临床研究
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

HBsAg 和HBV DNA 水平早期预测HBeAg 阴性的慢性乙肝患者聚乙二醇干扰素α-2a 治疗应答
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

评论文章:

抗逆转录病毒相关的肝毒性临床综合征及后果
Clinical syndromes and consequences of antiretroviral-related hepatotoxicity

肝硬化并发严重脓毒症
Severe sepsis in cirrhosis

编辑文章:

一步一个脚印:非酒精性脂肪肝炎生物标记物的识别与验证
One Step at a Time: Identification and Validation of Biomarkers for Nonalcoholic Steatohepatitis

对乙型肝炎病毒感染天然免疫应答的新认识是对以往 “隐形病毒”概念的挑战
Innate Response to Hepatitis B Virus Infection: Observations Challenging the Concept of a Stealth Virus

持续病毒学应答对代偿性肝硬化食管静脉曲张形成的长期影响:“权衡利弊”
Long-term effects of sustained virologic response on the development of esophageal varices in compensated cirrhosis: “Is the bang worth the buck?”

转氨酶轻度升高的慢性乙肝是否应该进行抗病毒治疗?
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?

铁在非酒精性脂肪性肝病发生中作用的新见解
New Insights into the Role of Iron in the Development of Nonalcoholic Fatty Liver Disease

肝硬化应用β 受体阻滞剂:是友是敌?
Beta-Blockers in Cirrhosis: Friend and Foe?

脂肪性肝炎/代谢性肝病:

肝组织学正常的亚洲人群血清丙氨酸氨基转移酶 正常值上限的估计
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations with Normal Liver Histology

水平升高对死亡风险的预测性
Ultrasonographic Hepatic Steatosis Increases Prediction of Mortality Risk From Elevated Serum Gamma-Glutamyl Transpeptidase Levels

自身免疫性、胆汁淤积性和胆道疾病:

药物诱导性自身免疫性肝炎:临床特征及预后
Drug-Induced Autoimmune Hepatitis: Clinical Characteristics and Prognosis

肝病的诊断和治疗进展:

药物治疗:替诺福韦
Drug Therapy: Tenofovir

美国肝病研究学会(AASLD)实践指南:

自身免疫性肝炎的诊断与治疗
Diagnosis and Management of Autoimmune Hepatitis

SEARCH

SEARCH BY CITATION